MULTIPLE SCLEROSIS IN 2010 Advances in monitoring and treatment of multiple sclerosis

被引：5
作者：
Filippi, Massimo [1 ,2 ]
机构：
[1] Inst Sci, Div Neurosci, Inst Expt Neurol, Neuroimaging Res Unit, I-20132 Milan, Italy
[2] Univ Hosp San Raffaele, I-20132 Milan, Italy
来源：
NATURE REVIEWS NEUROLOGY | 2011年 / 7卷 / 02期
关键词：
PLACEBO-CONTROLLED TRIAL; NEUTRALIZING ANTIBODIES; DIAGNOSTIC-CRITERIA; INTERFERON-BETA; ORAL FINGOLIMOD;
D O I：
10.1038/nrneurol.2010.215
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
2010 represented a milestone in the history of multiple sclerosis monitoring and treatment. MRI and immunological biomarkers were identified to track disease evolution and, ultimately, to guide treatment decisions. moreover, oral disease-modifying therapies emerged that should increase treatment regimen adherence and improve patient outcomes.
引用
收藏
页码：74 / 75
页数：2
相关论文
共 50 条
  • [31] The Role of Natalizumab in the Treatment of Multiple Sclerosis
    Coyle, Patricia K.
    AMERICAN JOURNAL OF MANAGED CARE, 2010, 16 (06) : S164 - S170
  • [32] Fingolimod for the treatment of relapsing multiple sclerosis
    Jeffery, Douglas R.
    Markowitz, Clyde E.
    Reder, Anthony T.
    Weinstock-Guttman, Bianca
    Tobias, Kathy
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2011, 11 (02) : 165 - 183
  • [33] Immunomodulatory drug treatment in multiple sclerosis
    Aharoni, Rina
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2010, 10 (09) : 1423 - 1436
  • [34] Fingolimod for the treatment of relapsing multiple sclerosis
    Singer, Barry A.
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2013, 13 (06) : 589 - 602
  • [35] Biomarkers of treatment response in multiple sclerosis
    Buck, Dorothea
    Hemmer, Bernhard
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2014, 14 (02) : 165 - 172
  • [36] Advances in the treatment of relapsing-remitting multiple sclerosis - critical appraisal of fingolimod
    Gasperini, Claudio
    Ruggieri, Serena
    Mancinelli, Chiara Rosa
    Pozzilli, Carlo
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2013, 9 : 73 - 85
  • [37] INNOVATIVE THERAPIES REDEFINE TREATMENT GOALS IN MULTIPLE SCLEROSIS
    Lazibat, Ines
    Samija, Radenka Kuzmanic
    Rotim, Kresimir
    ACTA CLINICA CROATICA, 2016, 55 (01) : 125 - 133
  • [38] Multiple sclerosis
    Nylander, Alyssa
    Hafler, David A.
    JOURNAL OF CLINICAL INVESTIGATION, 2012, 122 (04) : 1180 - 1188
  • [39] Multiple Sclerosis
    Courtney, Ardith M.
    Treadaway, Katherine
    Remington, Gina
    Frohman, Elliot
    MEDICAL CLINICS OF NORTH AMERICA, 2009, 93 (02) : 451 - +
  • [40] Daclizumab Treatment for Multiple Sclerosis
    Kim, Sylvia E.
    PHARMACOTHERAPY, 2009, 29 (02): : 227 - 235
12345